197 related articles for article (PubMed ID: 26358159)
1. Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
Suzuki S; Kuroda T; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Sugita R; Koishi R; Asano D; Tamaki K; Shinozuka T; Kobayashi H
Bioorg Med Chem Lett; 2015 Nov; 25(22):5419-23. PubMed ID: 26358159
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Novel Class of State-Dependent Na
Tanaka K; Kobayashi H; Suzuki S; Shibuya S; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Shinozuka T
Chem Pharm Bull (Tokyo); 2020; 68(7):653-663. PubMed ID: 32612000
[TBL] [Abstract][Full Text] [Related]
3. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
Sun S; Cohen CJ; Dehnhardt CM
Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
[TBL] [Abstract][Full Text] [Related]
5. Discovery of morpholine-based aryl sulfonamides as Na
Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
[TBL] [Abstract][Full Text] [Related]
6. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.
Payandeh J; Hackos DH
Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179
[TBL] [Abstract][Full Text] [Related]
7. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
8. Development of New Benzenesulfonamides As Potent and Selective Na
Wu YJ; Guernon J; Shi J; Ditta J; Robbins KJ; Rajamani R; Easton A; Newton A; Bourin C; Mosure K; Soars MG; Knox RJ; Matchett M; Pieschl RL; Post-Munson DJ; Wang S; Herrington J; Graef J; Newberry K; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
J Med Chem; 2017 Mar; 60(6):2513-2525. PubMed ID: 28234467
[TBL] [Abstract][Full Text] [Related]
9. An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite.
Catalano A; Carocci A; Lentini G; Defrenza I; Cavalluzzi MM; Franchini C
Drug Metab Lett; 2012 Jun; 6(2):124-8. PubMed ID: 22849704
[TBL] [Abstract][Full Text] [Related]
10. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.
Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z
Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Acyl-sulfonamide Na
Safina BS; McKerrall SJ; Sun S; Chen CA; Chowdhury S; Jia Q; Li J; Zenova AY; Andrez JC; Bankar G; Bergeron P; Chang JH; Chang E; Chen J; Dean R; Decker SM; DiPasquale A; Focken T; Hemeon I; Khakh K; Kim A; Kwan R; Lindgren A; Lin S; Maher J; Mezeyova J; Misner D; Nelkenbrecher K; Pang J; Reese R; Shields SD; Sojo L; Sheng T; Verschoof H; Waldbrook M; Wilson MS; Xie Z; Young C; Zabka TS; Hackos DH; Ortwine DF; White AD; Johnson JP; Robinette CL; Dehnhardt CM; Cohen CJ; Sutherlin DP
J Med Chem; 2021 Mar; 64(6):2953-2966. PubMed ID: 33682420
[TBL] [Abstract][Full Text] [Related]
12. The discovery and optimization of benzimidazoles as selective Na
Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
[TBL] [Abstract][Full Text] [Related]
13. Highly potent and selective Na
Storer RI; Pike A; Swain NA; Alexandrou AJ; Bechle BM; Blakemore DC; Brown AD; Castle NA; Corbett MS; Flanagan NJ; Fengas D; Johnson MS; Jones LH; Marron BE; Payne CE; Printzenhoff D; Rawson DJ; Rose CR; Ryckmans T; Sun J; Theile JW; Torella R; Tseng E; Warmus JS
Bioorg Med Chem Lett; 2017 Nov; 27(21):4805-4811. PubMed ID: 29029933
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
[TBL] [Abstract][Full Text] [Related]
15. Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na
Roecker AJ; Egbertson M; Jones KLG; Gomez R; Kraus RL; Li Y; Koser AJ; Urban MO; Klein R; Clements M; Panigel J; Daley C; Wang J; Finger EN; Majercak J; Santarelli V; Gregan I; Cato M; Filzen T; Jovanovska A; Wang YH; Wang D; Joyce LA; Sherer EC; Peng X; Wang X; Sun H; Coleman PJ; Houghton AK; Layton ME
Bioorg Med Chem Lett; 2017 May; 27(10):2087-2093. PubMed ID: 28389149
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
18. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
[TBL] [Abstract][Full Text] [Related]
19. Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.
Shcherbatko A; Rossi A; Foletti D; Zhu G; Bogin O; Galindo Casas M; Rickert M; Hasa-Moreno A; Bartsevich V; Crameri A; Steiner AR; Henningsen R; Gill A; Pons J; Shelton DL; Rajpal A; Strop P
J Biol Chem; 2016 Jul; 291(27):13974-13986. PubMed ID: 27129258
[TBL] [Abstract][Full Text] [Related]
20. The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.
Wu W; Li Z; Yang G; Teng M; Qin J; Hu Z; Hou L; Shen L; Dong H; Zhang Y; Li J; Chen S; Tian J; Zhang J; Ye L
Bioorg Med Chem Lett; 2017 May; 27(10):2210-2215. PubMed ID: 28385504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
